Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127


A fifty-year odyssey: Prospects for a cytomegalovirus vaccine in transplant and congenital infection.

Diamond DJ, La Rosa C, Chiuppesi F, Contreras H, Dadwal S, Wussow F, Bautista S, Nakamura R, Zaia JA.

Expert Rev Vaccines. 2018 Sep 22. doi: 10.1080/14760584.2018.1526085. [Epub ahead of print]


Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancers.

Chung V, Kos FJ, Hardwick N, Yuan Y, Chao J, Li D, Waisman J, Li M, Zurcher K, Frankel P, Diamond DJ.

Clin Transl Oncol. 2018 Aug 9. doi: 10.1007/s12094-018-1932-2. [Epub ahead of print]


Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.

Chiuppesi F, Nguyen J, Park S, Contreras H, Kha M, Meng Z, Kaltcheva T, Iniguez A, Martinez J, La Rosa C, Wussow F, Diamond DJ.

J Virol. 2018 Sep 12;92(19). pii: e01012-18. doi: 10.1128/JVI.01012-18. Print 2018 Oct 1.


p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy.

Hardwick NR, Frankel P, Ruel C, Kilpatrick J, Tsai W, Kos F, Kaltcheva T, Leong L, Morgan R, Chung V, Tinsley R, Eng M, Wilczynski S, Ellenhorn JDI, Diamond DJ, Cristea M.

Clin Cancer Res. 2018 Mar 15;24(6):1315-1325. doi: 10.1158/1078-0432.CCR-17-2709. Epub 2018 Jan 4.


Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab.

Yuan Y, Kos FJ, He TF, Yin HH, Li M, Hardwick N, Zurcher K, Schmolze D, Lee P, Pillai RK, Chung V, Diamond DJ.

Oncoimmunology. 2017 Aug 11;6(12):e1363138. doi: 10.1080/2162402X.2017.1363138. eCollection 2017.


Neutralization of Human Cytomegalovirus Entry into Fibroblasts and Epithelial Cells.

Wussow F, Chiuppesi F, Contreras H, Diamond DJ.

Vaccines (Basel). 2017 Oct 31;5(4). pii: E39. doi: 10.3390/vaccines5040039. Review.


Exploiting 2A peptides to elicit potent neutralizing antibodies by a multi-subunit herpesvirus glycoprotein complex.

Wussow F, Chiuppesi F, Meng Z, Martinez J, Nguyen J, Barry PA, Diamond DJ.

J Virol Methods. 2018 Jan;251:30-37. doi: 10.1016/j.jviromet.2017.10.006. Epub 2017 Oct 6.


Parenthood after reproductive loss: How psychotherapy can help with postpartum adjustment and parent-infant attachment.

Diamond DJ, Diamond MO.

Psychotherapy (Chic). 2017 Dec;54(4):373-379. doi: 10.1037/pst0000127. Epub 2017 Oct 2. Review.


Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice.

Chiuppesi F, Wussow F, Scharf L, Contreras H, Gao H, Meng Z, Nguyen J, Barry PA, Bjorkman PJ, Diamond DJ.

PLoS One. 2017 Aug 16;12(8):e0183377. doi: 10.1371/journal.pone.0183377. eCollection 2017.


Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.

Nelson CS, Cruz DV, Tran D, Bialas KM, Stamper L, Wu H, Gilbert M, Blair R, Alvarez X, Itell H, Chen M, Deshpande A, Chiuppesi F, Wussow F, Diamond DJ, Vandergrift N, Walter MR, Barry PA, Cohen-Wolkowiez M, Koelle K, Kaur A, Permar SR.

JCI Insight. 2017 Jul 6;2(13). pii: 94002. doi: 10.1172/jci.insight.94002. [Epub ahead of print]


The pancreatic cancer microenvironment: A true double agent.

Melstrom LG, Salazar MD, Diamond DJ.

J Surg Oncol. 2017 Jul;116(1):7-15. doi: 10.1002/jso.24643. Epub 2017 Jun 12. Review.


Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV Transmission.

Fan Q, Nelson CS, Bialas KM, Chiuppesi F, Amos J, Gurley TC, Marshall DJ, Eudailey J, Heimsath H, Himes J, Deshpande A, Walter MR, Wussow F, Diamond DJ, Barry PA, Moody MA, Kaur A, Permar SR.

Clin Vaccine Immunol. 2017 May 5;24(5). pii: e00510-16. doi: 10.1128/CVI.00510-16. Print 2017 May.


Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus.

Chiuppesi F, Kaltcheva T, Meng Z, Barry PA, Diamond DJ, Wussow F.

J Virol. 2017 Feb 28;91(6). pii: e01857-16. doi: 10.1128/JVI.01857-16. Print 2017 Mar 15.


MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.

La Rosa C, Longmate J, Martinez J, Zhou Q, Kaltcheva TI, Tsai W, Drake J, Carroll M, Wussow F, Chiuppesi F, Hardwick N, Dadwal S, Aldoss I, Nakamura R, Zaia JA, Diamond DJ.

Blood. 2017 Jan 5;129(1):114-125. doi: 10.1182/blood-2016-07-729756. Epub 2016 Oct 19.


Evaluation of innate and adaptive immunity contributing to the antitumor effects of PD1 blockade in an orthotopic murine model of pancreatic cancer.

D'Alincourt Salazar M, Manuel ER, Tsai W, D'Apuzzo M, Goldstein L, Blazar BR, Diamond DJ.

Oncoimmunology. 2016 Mar 16;5(6):e1160184. doi: 10.1080/2162402X.2016.1160184. eCollection 2016 Jun.


The susceptibility of primary cultured rhesus macaque kidney epithelial cells to rhesus cytomegalovirus strains.

Yue Y, Kaur A, Lilja A, Diamond DJ, Walter MR, Barry PA.

J Gen Virol. 2016 Jun;97(6):1426-38. doi: 10.1099/jgv.0.000455. Epub 2016 Mar 14.


Developing Effective Salmonella-based Approaches to Treat Pancreatic Cancer.

Chen J, Diamond DJ, Manuel ER.

Pancreat Disord Ther. 2016;6(1):1-2. No abstract available.


Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial.

Nakamura R, La Rosa C, Longmate J, Drake J, Slape C, Zhou Q, Lampa MG, O'Donnell M, Cai JL, Farol L, Salhotra A, Snyder DS, Aldoss I, Forman SJ, Miller JS, Zaia JA, Diamond DJ.

Lancet Haematol. 2016 Feb;3(2):e87-98. doi: 10.1016/S2352-3026(15)00246-X. Epub 2015 Dec 24.


Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients.

Limaye AP, La Rosa C, Longmate J, Diamond DJ.

Transplantation. 2016 Jan;100(1):210-6. doi: 10.1097/TP.0000000000000816.


Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.

Bialas KM, Tanaka T, Tran D, Varner V, Cisneros De La Rosa E, Chiuppesi F, Wussow F, Kattenhorn L, Macri S, Kunz EL, Estroff JA, Kirchherr J, Yue Y, Fan Q, Lauck M, O'Connor DH, Hall AH, Xavier A, Diamond DJ, Barry PA, Kaur A, Permar SR.

Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13645-50. doi: 10.1073/pnas.1511526112. Epub 2015 Oct 19.


CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT.

Cichocki F, Cooley S, Davis Z, DeFor TE, Schlums H, Zhang B, Brunstein CG, Blazar BR, Wagner J, Diamond DJ, Verneris MR, Bryceson YT, Weisdorf DJ, Miller JS.

Leukemia. 2016 Feb;30(2):456-63. doi: 10.1038/leu.2015.260. Epub 2015 Sep 29.


Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.

Chiuppesi F, Wussow F, Johnson E, Bian C, Zhuo M, Rajakumar A, Barry PA, Britt WJ, Chakraborty R, Diamond DJ.

J Virol. 2015 Dec;89(23):11884-98. doi: 10.1128/JVI.01701-15. Epub 2015 Sep 16.


Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors.

Manuel ER, Chen J, D'Apuzzo M, Lampa MG, Kaltcheva TI, Thompson CB, Ludwig T, Chung V, Diamond DJ.

Cancer Immunol Res. 2015 Sep;3(9):1096-107. doi: 10.1158/2326-6066.CIR-14-0214. Epub 2015 Jul 1.


Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.

Swanson EC, Gillis P, Hernandez-Alvarado N, Fernández-Alarcón C, Schmit M, Zabeli JC, Wussow F, Diamond DJ, Schleiss MR.

Vaccine. 2015 Jul 31;33(32):4013-8. doi: 10.1016/j.vaccine.2015.06.019. Epub 2015 Jun 13.


Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation.

Davis ZB, Cooley SA, Cichocki F, Felices M, Wangen R, Luo X, DeFor TE, Bryceson YT, Diamond DJ, Brunstein C, Blazar BR, Wagner JE, Weisdorf DJ, Horowitz A, Guethlein LA, Parham P, Verneris MR, Miller JS.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1653-62. doi: 10.1016/j.bbmt.2015.05.025. Epub 2015 Jun 6.


Overcoming immunosuppression to enhance a p53MVA vaccine.

Hardwick N, Chung V, Cristea M, Ellenhorn JD, Diamond DJ.

Oncoimmunology. 2014 Dec 15;3(10):e958949. eCollection 2014 Nov.


CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells.

Wang X, Wong CW, Urak R, Mardiros A, Budde LE, Chang WC, Thomas SH, Brown CE, La Rosa C, Diamond DJ, Jensen MC, Nakamura R, Zaia JA, Forman SJ.

Clin Cancer Res. 2015 Jul 1;21(13):2993-3002. doi: 10.1158/1078-0432.CCR-14-2920. Epub 2015 Apr 2.


Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection.

Gibson L, Barysauskas CM, McManus M, Dooley S, Lilleri D, Fisher D, Srivastava T, Diamond DJ, Luzuriaga K.

J Clin Immunol. 2015 Apr;35(3):289-301. doi: 10.1007/s10875-015-0139-3. Epub 2015 Feb 25.


Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.

Wussow F, Chiuppesi F, Martinez J, Campo J, Johnson E, Flechsig C, Newell M, Tran E, Ortiz J, La Rosa C, Herrmann A, Longmate J, Chakraborty R, Barry PA, Diamond DJ.

PLoS Pathog. 2014 Nov 20;10(11):e1004524. doi: 10.1371/journal.ppat.1004524. eCollection 2014 Nov.


Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation.

Israyelyan A, Goldstein L, Tsai W, Aquino L, Forman SJ, Nakamura R, Diamond DJ.

Bone Marrow Transplant. 2015 Jan;50(1):26-33. doi: 10.1038/bmt.2014.209. Epub 2014 Sep 22.


Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system.

Xu X, Hegazy WA, Guo L, Gao X, Courtney AN, Kurbanov S, Liu D, Tian G, Manuel ER, Diamond DJ, Hensel M, Metelitsa LS.

Cancer Res. 2014 Nov 1;74(21):6260-70. doi: 10.1158/0008-5472.CAN-14-1169. Epub 2014 Sep 11.


p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responses.

Hardwick NR, Carroll M, Kaltcheva T, Qian D, Lim D, Leong L, Chu P, Kim J, Chao J, Fakih M, Yen Y, Espenschied J, Ellenhorn JD, Diamond DJ, Chung V.

Clin Cancer Res. 2014 Sep 1;20(17):4459-70. doi: 10.1158/1078-0432.CCR-13-3361. Epub 2014 Jul 1. Erratum in: Clin Cancer Res. 2017 Jan 1;23 (1):322.


Development of a novel, guinea pig-specific IFN-γ ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccine.

Gillis PA, Hernandez-Alvarado N, Gnanandarajah JS, Wussow F, Diamond DJ, Schleiss MR.

Vaccine. 2014 Jun 30;32(31):3963-70. doi: 10.1016/j.vaccine.2014.05.011. Epub 2014 May 20.


Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients.

Nakamura R, La Rosa C, Tsai W, Lacey SF, Srivastava T, Seidel A, Senitzer D, Forman SJ, Diamond DJ.

Transpl Immunol. 2014 May;30(4):128-35. doi: 10.1016/j.trim.2014.02.001. Epub 2014 Feb 26.


TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy.

Gao C, Kozlowska A, Nechaev S, Li H, Zhang Q, Hossain DM, Kowolik CM, Chu P, Swiderski P, Diamond DJ, Pal SK, Raubitschek A, Kortylewski M.

Cancer Res. 2013 Dec 15;73(24):7211-21. doi: 10.1158/0008-5472.CAN-13-1314. Epub 2013 Oct 23.


DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus.

Gil A, Shen S, Coley S, Gibson L, Diamond DJ, Wang S, Lu S.

Hum Vaccin Immunother. 2013 Oct;9(10):2120-32. doi: 10.4161/hv.25750. Epub 2013 Jul 25.


Tumor growth control with IDO-silencing Salmonella--reply.

Manuel ER, Blazar BR, Diamond DJ.

Cancer Res. 2013 Jul 15;73(14):4592-3. doi: 10.1158/0008-5472.CAN-13-1274. Epub 2013 Jul 5. No abstract available.


Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma.

Israyelyan A, La Rosa C, Tsai W, Kaltcheva T, Srivastava T, Aquino L, Li J, Kim Y, Palmer J, Streja L, Senitzer D, Zaia JA, Rosenwald A, Forman SJ, Nakamura R, Diamond DJ.

Leuk Lymphoma. 2013 Nov;54(11):2490-9. doi: 10.3109/10428194.2013.783910. Epub 2013 Apr 30.


The immune response to human CMV.

La Rosa C, Diamond DJ.

Future Virol. 2012 Mar 1;7(3):279-293.


A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.

Wussow F, Yue Y, Martinez J, Deere JD, Longmate J, Herrmann A, Barry PA, Diamond DJ.

J Virol. 2013 Feb;87(3):1322-32. doi: 10.1128/JVI.01669-12. Epub 2012 Nov 14.


Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth.

Blache CA, Manuel ER, Kaltcheva TI, Wong AN, Ellenhorn JD, Blazar BR, Diamond DJ.

Cancer Res. 2012 Dec 15;72(24):6447-56. doi: 10.1158/0008-5472.CAN-12-0193. Epub 2012 Oct 22.


Intracerebral CpG immunotherapy with carbon nanotubes abrogates growth of subcutaneous melanomas in mice.

Fan H, Zhang I, Chen X, Zhang L, Wang H, Da Fonseca A, Manuel ER, Diamond DJ, Raubitschek A, Badie B.

Clin Cancer Res. 2012 Oct 15;18(20):5628-38. doi: 10.1158/1078-0432.CCR-12-1911. Epub 2012 Aug 17.


Survivin the battle against immunosuppression.

Manuel ER, Blache CA, Ellenhorn JD, Diamond DJ.

Oncoimmunology. 2012 Mar 1;1(2):240-241.


Patterns of acute rhesus cytomegalovirus (RhCMV) infection predict long-term RhCMV infection.

Assaf BT, Mansfield KG, Westmoreland SV, Kaur A, Oxford KL, Diamond DJ, Barry PA.

J Virol. 2012 Jun;86(11):6354-7. doi: 10.1128/JVI.00607-12. Epub 2012 Apr 4.


Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.

La Rosa C, Longmate J, Lacey SF, Kaltcheva T, Sharan R, Marsano D, Kwon P, Drake J, Williams B, Denison S, Broyer S, Couture L, Nakamura R, Dadwal S, Kelsey MI, Krieg AM, Diamond DJ, Zaia JA.

J Infect Dis. 2012 Apr 15;205(8):1294-304. doi: 10.1093/infdis/jis107. Epub 2012 Mar 7. Erratum in: J Infect Dis. 2013 Sep;208(6):1038. Dadwal, Sanjeet [added].


Recombinant modified vaccinia virus ankara (MVA) expressing wild-type human p53 induces specific antitumor CTL expansion.

Song GY, Srivastava T, Ishizaki H, Lacey SF, Diamond DJ, Ellenhorn JD.

Cancer Invest. 2011 Oct;29(8):501-10. doi: 10.3109/07357907.2011.606248. Epub 2011 Aug 15.


Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice.

Lacey SF, La Rosa C, Kaltcheva T, Srivastava T, Seidel A, Zhou W, Rawal R, Hagen K, Krishnan A, Longmate J, Andersson HA, St John L, Bhatia R, Pullarkat V, Forman SJ, Cooper LJ, Molldrem J, Diamond DJ.

Blood. 2011 Aug 25;118(8):2159-69. doi: 10.1182/blood-2011-04-349951. Epub 2011 Jun 30.


Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients.

La Rosa C, Limaye AP, Krishnan A, Blumstein G, Longmate J, Diamond DJ.

Transpl Int. 2011 Sep;24(9):920-31. doi: 10.1111/j.1432-2277.2011.01285.x. Epub 2011 Jun 14.


Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors.

Manuel ER, Blache CA, Paquette R, Kaltcheva TI, Ishizaki H, Ellenhorn JD, Hensel M, Metelitsa L, Diamond DJ.

Cancer Res. 2011 Jun 15;71(12):4183-91. doi: 10.1158/0008-5472.CAN-10-4676. Epub 2011 Apr 28.

Supplemental Content

Loading ...
Support Center